EMILY NARDIELLO: Open Payments
NPI 1528454717 · ISSAQUAH, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 50 payments from 11 companies in 2025. Trend: 2023 $725 · 2024 $763 · 2025 $854
Food & beverage: $779Education: $75
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $229 |
| Novartis Pharmaceuticals Corporation | 22 | $174 |
| Janssen Biotech, Inc. | 2 | $96 |
| ABBVIE INC. | 3 | $72 |
| Lilly USA, LLC | 3 | $70 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $70 |
| Galderma Laboratories, L.P. | 3 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Amgen Inc. | 1 | $27 |
| Organon LLC | 1 | $21 |
Products named: DUPIXENT, COSENTYX, TREMFYA, SKYRIZI, TALTZ, Winlevi, AKLIEF, OTEZLA.
Industry payments across WA — which companies pay providers there.
